Results 24,821-24,840 of 34,778 for speaker:Seán Fleming
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Where was it in more than one place up to now?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Essentially, Mr. Barry O'Brien is stating that the people who signed this agreement the last time did not have an overall picture of what they were signing. That is the implication. Mr. O'Brien is telling me his Department is getting bits from here and there and how an overall picture is needed. By implication, he is stating that the people who signed the last agreement did not have an...
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Mr. O'Brien stated that his Department was obliged to collect the data in order to consolidate it all into one overall picture, which was not-----
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Which was not there previously.
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Mr. O'Brien must know. I do not like beating around the bush in this regard. If this information was there previously, the Department would not need to be doing this exercise now. If the Department is now obliged to do this, it must not have been available previously. Mr. O'Brien should give it to members straight. If the information was there previously, why is the Department doing this now?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Right, and it is helpful if the Department is putting it together. Consequently, the involvement of the Department and the aforementioned office should yield a benefit, ultimately, but it probably is leading to a delay in the commencement and the negotiations while it is engaged in this task that had not been done in this manner previously. I revert to the extract I read out from the...
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Explain the relevance of the aforementioned paragraph, if everything was so hunky-dory. What is that paragraph doing there?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Very well. I seek a brief comment. IPHA is the Irish pharmaceutical representative association. I think we had this discussion here previously. The Association of Pharmaceutical Manufacturers of Ireland is another body. Some products are in patent while others are out of patent. A third group is generic. In respect of which group is the HSE negotiating with the IPHA? Are they the...
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Is the commencement of both negotiations stalled?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: What about suppliers who are not part of the IPHA? Many of us were lobbied during the year about treatment for particular people, for example, blood treatment and people having to have many of blood transfusions. While we are having this negotiation with the IPHA, how many other pharmaceutical drug suppliers are supplying the HSE on a company-by-company basis that is not covered by this...
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Could the HSE send us a list?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Does the HSE have to negotiate with them on a company-by-company basis because they are not part of the IPHA?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Who negotiates with them? Do they negotiate with the HSE on a one-to-one basis?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: My apologies to the Chairman but this is almost the biggest bill the taxpayer has to pay. The IPHA is a federation for some of the suppliers. It comes in and talks to the HSE. Would the HSE not be better off talking to all the companies on a one-to-one basis because it would strike a better deal? If there are 20 companies, the HSE can separate them and work one off against the other as...
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Tell them that. Who is writing the cheque?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: There is one little issue that has been touched on.
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: I have two final questions on this topic. I notice that the witnesses keep referring to negotiating a "framework". They use that phrase when they are talking about the negotiations. Who negotiates the price? Is it the medicines board? Who actually decides that the price for a given product or tablet is a certain amount?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Who decides on the actual prices of the actual medicines that people get on the shelves of their pharmacies?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Who is the medicines board, or the Health Products Regulatory Authority? Who are they?
- Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015) Seán Fleming: Does it have a role in relation to price?